Weiss Multi-Strategy Advisers’s Autolus Therapeutics AUTL Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,324	Closed	-$29K	–	588
2022 Q3	$29K	Sell	13,324 -429	-3%	-$1.27K	﹤0.01%	635
2022 Q2	$39K	Sell	13,753 -723	-5%	-$2.2K	﹤0.01%	637
2022 Q1	$60K	Sell	14,476 -256	-2%	-$1.08K	﹤0.01%	644
2021 Q4	$76K	Sell	14,732 -60	-0.4%	-$360	﹤0.01%	629
2021 Q3	$97K	Buy	14,792 +342	+2%	+$2.16K	﹤0.01%	654
2021 Q2	$96K	Buy	14,450 +516	+4%	+$3.2K	﹤0.01%	654
2021 Q1	$80K	Sell	13,934 -4,592	-25%	-$34K	﹤0.01%	684
2020 Q4	$166K	Sell	18,526 -31,785	-63%	-$339K	﹤0.01%	656
2020 Q3	$586K	Buy	50,311 +558	+1%	+$8.09K	0.02%	465
2020 Q2	$798K	Buy	49,753 +1,600	+3%	+$17.7K	0.02%	433
2020 Q1	$288K	Sell	48,153 -1,847	-4%	-$17.1K	0.01%	372
2019 Q4	$660K	Hold	50,000	–	–	0.01%	524
2019 Q3	$621K	Hold	50,000	–	–	0.01%	478
2019 Q2	$805K	Buy	50,000 +20,000	+67%	+$447K	0.02%	393
2019 Q1	$944K	Buy	30,000 +3,000	+11%	+$85.3K	0.02%	400
2018 Q4	$887K	Sell	27,000 -6,043	-18%	-$199K	0.04%	308
2018 Q3	$1.01M	Sell	33,043 -8,086	-20%	-$218K	0.03%	395
2018 Q2	$1.1M	Buy	+41,129	New	+$1.09M	0.03%	425

Other funds holding AUTL

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

OAMG

Odey Asset Management Group London, United Kingdom $381M AUM 45.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AUTL Position: Q4 2022 in Review

Weiss Multi-Strategy Advisers sold out of Autolus Therapeutics (AUTL) in Q4 2022, closing a stake of 13,324 shares — an estimated $29K sold.

Weiss Multi-Strategy Advisers first reported a position in AUTL in Q2 2018 and held it in 18 quarters. The position peaked at $1.1M in Q2 2018. 71 funds tracked by Wall St. Rank hold AUTL as of Q4 2022.

Weiss Multi-Strategy Advisers reported no remaining Autolus Therapeutics position as of Q4 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 13,324 Autolus Therapeutics shares in Q4 2022, an estimated $29K.
Weiss Multi-Strategy Advisers first reported a position in Autolus Therapeutics in Q2 2018 and held it in 18 quarters.
Weiss Multi-Strategy Advisers's Autolus Therapeutics position peaked at $1.1M in Q2 2018.
71 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.